Orion Biotech Opportunities (Orion Biotech Opportunities) Debt-to-Equity : 0.00 (As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Orion Biotech Opportunities Debt-to-Equity?

Orion Biotech Opportunities's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $0.00 Mil. Orion Biotech Opportunities's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $0.00 Mil. Orion Biotech Opportunities's Total Stockholders Equity for the quarter that ended in Dec. 2022 was $195.00 Mil. Orion Biotech Opportunities's debt to equity for the quarter that ended in Dec. 2022 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Orion Biotech Opportunities's Debt-to-Equity or its related term are showing as below:

ORIAU's Debt-to-Equity is not ranked ^*
in the Diversified Financial Services industry.
Industry Median: 0.13
* Ranked among companies with meaningful Debt-to-Equity only.

Orion Biotech Opportunities Debt-to-Equity Historical Data

The historical data trend for Orion Biotech Opportunities's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Biotech Opportunities Debt-to-Equity Chart

Orion Biotech Opportunities Annual Data

Trend

Dec21

Dec22

Debt-to-Equity

Orion Biotech Opportunities Quarterly Data
	Feb21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Debt-to-Equity	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Orion Biotech Opportunities's Debt-to-Equity

For the Shell Companies subindustry, Orion Biotech Opportunities's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orion Biotech Opportunities's Debt-to-Equity Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Orion Biotech Opportunities's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Orion Biotech Opportunities's Debt-to-Equity falls into.

Orion Biotech Opportunities Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Orion Biotech Opportunities's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	195.001
	=	0.00

Orion Biotech Opportunities's Debt to Equity Ratio for the quarter that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	195.001
	=	0.00

Orion Biotech Opportunities (OTCPK:ORIAU) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Orion Biotech Opportunities Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Orion Biotech Opportunities's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.